Hu S - Search Results

1

[Predictors of the no-reflow phenomenon after primary percutaneous coronary intervention for acute myocardial infarction].

Zhao Y, Chen Y, Tian F, Wang C, Hu S, Wang J, Yang J. Zhao Y, et al. Among authors: hu s. Nan Fang Yi Ke Da Xue Xue Bao. 2012 Feb;32(2):261-4. Nan Fang Yi Ke Da Xue Xue Bao. 2012. PMID: 22381773 Chinese.

2

Effects of adenovirus-mediated delivery of the human hepatocyte growth factor gene in experimental radiation-induced heart disease.

Hu S, Chen Y, Li L, Chen J, Wu B, Zhou X, Zhi G, Li Q, Wang R, Duan H, Guo Z, Yang Y, Xiao F, Wang H, Wang L. Hu S, et al. Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1537-44. doi: 10.1016/j.ijrobp.2009.07.1697. Int J Radiat Oncol Biol Phys. 2009. PMID: 19931736

3

[Characteristics of traditional risk factors and coronary lesions on coronary heart disease among different sex populations].

Zhao Y, Tian F, Hu SY, Wang J, Zhang T, Chen YD, He Y. Zhao Y, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Apr;33(4):423-7. Zhonghua Liu Xing Bing Xue Za Zhi. 2012. PMID: 22781419 Chinese.

4

Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.

Chen Y, Hu S, Liu Y, Zhao R, Wang L, Fu G, He Q, Su X, Zheng Y, Qi X, Liu H, Wang J, Gao W, Wang M, Liu S, Zheng X, He B, Yang P, Zhou S, Gao C, Qiu C. Chen Y, et al. Among authors: hu s. EuroIntervention. 2012 Nov 22;8(7):830-8. doi: 10.4244/EIJV8I7A126. EuroIntervention. 2012. PMID: 23045301 Free article. Clinical Trial.

5

The stem cell adjuvant with Exendin-4 repairs the heart after myocardial infarction via STAT3 activation.

Liu J, Wang H, Wang Y, Yin Y, Du Z, Liu Z, Yang J, Hu S, Wang C, Chen Y. Liu J, et al. Among authors: hu s. J Cell Mol Med. 2014 Jul;18(7):1381-91. doi: 10.1111/jcmm.12272. Epub 2014 Apr 30. J Cell Mol Med. 2014. PMID: 24779911 Free PMC article.

6

Hepatocyte growth factor suppresses hypoxia/reoxygenation-induced XO activation in cardiac microvascular endothelial cells.

Zhang Y, Hu S, Chen Y. Zhang Y, et al. Among authors: hu s. Heart Vessels. 2015 Jul;30(4):534-44. doi: 10.1007/s00380-014-0547-y. Epub 2014 Jul 26. Heart Vessels. 2015. PMID: 25062711

7

[Exendin-4 promotes paracrine action of adipose-derived stem cells through PI3K/Akt signaling pathways].

Zhou H, Yang J, Wagn J, Hu S, Chen G, Chen Y. Zhou H, et al. Among authors: hu s. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Oct;34(10):1395-401. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 25345931 Chinese.

8

Risk stratification and prognostic value of grace and timi risk scores for female patients with non-st segment elevation acute coronary syndrome.

Zhu H, Xue H, Wang H, Chen Y, Zhou S, Tian F, Hu S, Wang J, Yang J, Zhang T. Zhu H, et al. Among authors: hu s. Int J Clin Exp Med. 2015 Mar 15;8(3):4038-44. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26064307 Free PMC article.

9

[Liraglutide promotes proliferation and migration of cardiac microvascular endothelial cells through PI3K/Akt and MAPK/ERK signaling pathways].

Zhang Y, Hu SY, Yin T, Tian F, Wang S, Zhang Y, Chen Y. Zhang Y, et al. Among authors: hu sy. Nan Fang Yi Ke Da Xue Xue Bao. 2015 Aug;35(9):1221-6. Nan Fang Yi Ke Da Xue Xue Bao. 2015. PMID: 26403728 Chinese.

10

Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Chen WR, Hu SY, Chen YD, Zhang Y, Qian G, Wang J, Yang JJ, Wang ZF, Tian F, Ning QX. Chen WR, et al. Am Heart J. 2015 Nov;170(5):845-54. doi: 10.1016/j.ahj.2015.07.014. Epub 2015 Jul 26. Am Heart J. 2015. PMID: 26542491 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,475 results

Search Page

Filters